Pedro Pesini

Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA.

Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA.

Scranton Enterprises BV is a private equity firm with its headquarters in Amsterdam, the Netherlands.

Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA.

Part of Grifols SA, Talecris Plasma Resources, Inc. owns and operates plasma collection centers. The company is based in Toledo, OH.

BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA.

Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain.

Barcelona Cartonboard S.A.U. manufactures and supplies cardboard. It produces cardboard made from recycled fibres and virgin fibers for various sectors, including the hardware and cleaning, textile, food, pharmacy and graphic sectors. The company was founded in 1967 and is headquartered in Castellbisbal, Spain.

Tojosnura SL provides legal services. The company was founded by Tomas Daga Gelabert and is headquartered in Barcelona, Spain.

Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million.

Part of Grifols SA, Gri-Cel SA provides investment services. The company is based in Barcelona, Spain. The CEO of the Spanish company is Dirk Büscher.

Grifols Worldwide Operations Ltd. manufactures and develops pharmaceutical products. The company was founded in 2013 and is headquartered in Dublin, Ireland.

Part of Grifols SA, Kiro Grífols SL is a Spanish company located in Arrasate that provides automated robotics technology. On July 24, 2017 Grifols SA acquired Kiro Grífols SL from Mondragon S. Coop for $14.92 million.

Probitas Foundation promotes and finances various activities and cooperative programs to improve healthcare. The private company is based in Barcelona, Spain.

Grifols Innovation & New Technologies Ltd. provides research and experimental development services in biotechnology sector. The company was founded on December 21, 2015 and is headquartered in Dublin, Ireland.

Osborne Clarke is a Spanish company that offers legal services to various sectors including life sciences, tech, media and communications, renewable energy, financial services and real estate. The private company is based in Madrid, Spain. The company was founded by Tomás Dagá Gelabert.

Part of Grifols SA, Grifols Canada Therapeutics, Inc. is a Canadian company that produces plasma-derived medicines. The company is based in Saint-Laurent, Canada.